Search Results 1491-1500 of 38505 for oral

  1. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

    The study will evaluate oral daily administration of eFT508. Treatment and study subject evaluation will be performed in 21-day cycles. Participation ...

  2. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    This phase II trial studies how well giving ruxolitinib phosphate (oral JAK inhibitor INCB18424) works in treating patients with relapsed or refractory diffuse ...

  3. Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects with Recurrence of Clostridium difficile Infection - Mayo Clinic

    Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects with Recurrence of Clostridium difficile Infection · More about research at Mayo Clinic.

  4. Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. - Mayo Clinic

    Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. · More about research at Mayo Clinic.

  5. Levamisole (oral route) - Side effects & dosage - Mayo Clinic

    Levamisole is used with another cancer medicine (fluorouracil) to help make it work better against cancer of the colon. Levamisole is available only with your ...

  6. Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In Situ - Mayo Clinic

    The purpose of this study is to analyze breast tissue changes after a short course of Tamoxifen (Tam). Participation eligibility. Participant eligibility ...

  7. Levoketoconazole (oral route) - Side effects & dosage - Mayo Clinic

    For oral dosage form (tablets):. For hypercortisolemia: Adults—At first, 150 milligrams (mg) 2 times a day. Your doctor may adjust your dose as needed and ...

  8. Elise W. Sarvas, D.D.S., M.S.

    Comprehensive, consultative, and emergency pediatric oral health services; Preventive and therapeutic pediatric dental services for individuals with complex ...

  9. Registry of Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Thromboembolic Prevention in Patients with Congenital Heart Disease - Mayo Clinic

    Registry of Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Thromboembolic Prevention in Patients with Congenital Heart Disease.

  10. A Study To Evaluate The Effects Of Oral Levosimendan (ODM-109) On Respiratory Function In Patients With ALS - Mayo Clinic

    The purpose of this study is to evaluate whether prolonged oral levosimendan can preserve respiratory function more effectively than placebo, resulting in ...